In this podcast, I continue our rapid review series for the USMLE Step 2CK/3 exams by discussing a host of tricky endocrinology and pharmacology vignettes. HY stuff here for sure. Audio Download
Nov 22
25 Hour Step 1 Basic Science Review (12/1-5, 2025)
In this short podcast, I discuss the upcoming 25 Hour USMLE Step 1 Basic Science Review taking place on zoom from 6-11 pm EST from 12/1-5. The review will be incredibly clinical, focus on integrations, help you understand pathophysiology, and expose you to a large amount of the S ... Show More
6m 18s
Nov 15
December 2025 Step 1-3 USMLE/COMLEX Classes (including 25 Hour Step 1 Review from 12/1-5)
In this podcast, I explain exactly what you should expect to get from all my classes. I go over each class and discuss the way they are structured, specific advantages offered by each class, and my approach to covering the material. I discuss differences between the classes and m ... Show More
26m 51s
May 2025
Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ... Show More
25m 58s
Sep 2024
Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More
31m 56s
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More
36m 11s
Sep 2024
Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my!
<p>This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future ... Show More
35m 14s
Dec 2024
Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML
<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transp ... Show More
26m 12s
Jan 2024
Radiology in 2024. Interview with Tamara Lundeen MD, Ryan Avery MD, and Phillip Kuo MD, PhD
Please join us for this interview with Drs. Lundeen, Avery, and Kuo, as we look back on top trends in 2023 and look forward to the future of radiology in 2024 and beyond. Topics discussed include the radiology job market, artificial intelligence, teleradiology, nuclear medicine t ... Show More
1h 6m